source
- Lilly pens deal with Gateway Labs alumni Amplitude for RNA vaccine platform for infectious diseaseEli Lilly has turned to one of its Gateway Labs residents to help the Big Pharma develop trans-amplifying RNA (taRNA) vaccines for infectious diseases.Fierce Biotech · 6h ago↗ source
- FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vaxStrain selection timing and mRNA skepticism could limit the impact of Moderna’s game-changing mRNA flu shot.